![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » RANBAXY, MAX SETTLE DISPUTE OVER SINGH'S WILL
RANBAXY, MAX SETTLE DISPUTE OVER SINGH'S WILL
July 31, 2006
Ranbaxy chief Malvinder Singh and Max Healthcare chairman Analjit Singh said they have reached a settlement on the will of Ranbaxy founder Bhai Mohan Singh and decided to withdraw all cases against each other.
The Economic Times (http://economictimes.indiatimes.com/articleshow/1832536.cms)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct